ROYAL BANK OF CANADA - NRX PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of NRX PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$44,000
-47.0%
170,419
-0.5%
0.00%
Q2 2023$83,000171,233
+135799.2%
0.00%
Q1 2023$0126
-1.6%
0.00%
Q4 2022$0128
-59.7%
0.00%
Q3 2022$0318
-39.2%
0.00%
Q2 2022$0
-100.0%
523
-93.5%
0.00%
Q2 2021$93,0008,0000.00%
Other shareholders
NRX PHARMACEUTICALS INC shareholders Q4 2023
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 325,000$84,5000.06%
Texas Capital Bank Wealth Management Services Inc 63,290$16,4550.00%
XTX Topco Ltd 11,809$3,0700.00%
United Asset Strategies, Inc. 18,300$4,7580.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 160,700$41,7820.00%
UBS Group AG 1,210$3150.00%
NewEdge Advisors, LLC 7,125$1,8530.00%
Lido Advisors, LLC 13,000$3,3800.00%
OSAIC HOLDINGS, INC. 11,125$2,8910.00%
WELLS FARGO & COMPANY/MN 5,379$1,3990.00%
View complete list of NRX PHARMACEUTICALS INC shareholders